Here are three things to know.
1. Aseptic loosening and periprosthetic bacterial infection are the two leading causes of implant failure.
2. The new technology includes a metal implant with hydroxyapatite coating loaded with antibiotics. It is designed to maintain osseointegration while providing sustained antibiotic release to the target area to prevent infection. The implant coating continuously releases the drug up to 180 hours after implantation.
3. Biotech Consortium India Limited acquired the technology.
More articles on surface technology:
DePuy Synthes to promote Fibergraft for spine fusion: 4 insights
Does spine implant coating effect spinal fusion outcomes? — 5 study findings
3 things to know about a surface treatment to reduce implant rejection
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 18–20 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
